NCT05775237

Brief Summary

An Open-Label, Three-Arm, Parallel, Investigator-Initiated Trial of Three Different Gummies (Curcumin Gummies, Vitamin C Gummies, and Vitamin B Complex Gummies) in Healthy Children. A sufficient number (maximum of 48, (16 children/arm)) of children subjects will be recruited to ensure a total of 45 subjects (15 children /arm) complete the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 7, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 20, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 6, 2023

Completed
Last Updated

November 9, 2023

Status Verified

November 1, 2023

Enrollment Period

1 month

First QC Date

March 7, 2023

Last Update Submit

November 7, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Assessment of Safety

    To evaluate the Safety of Test Product by using subject perception questionnaires regarding Health

    Day 01 before test product usage to 30 Day after Test product usage

  • Assessment of Efficacy

    To evaluate the Efficacy of Test Product by using subject perception questionnaires regarding Health

    Day 01 before test product usage to 30 Day after Test product usage

  • Assessment of Organoleptic properties

    To evaluate the Organoleptic properties of Test Product by using subject perception questionnaires regarding Test Product

    30 Day after usage of Test product

Study Arms (3)

Curcumin Gummies

EXPERIMENTAL

Curcumin Gummies contain energy, dietary fiber, sugar, total carbohydrate, protein, fat, and curcumin.

Dietary Supplement: Curcumin Gummies

Vitamin C Gummies

EXPERIMENTAL

Vitamin C Gummies contain Vitamin C and Zinc

Dietary Supplement: Vitamin C Gummies

Multivitamin Gummies

EXPERIMENTAL

Multivitamin Gummies contain energy, dietary fiber, sugar, total carbohydrate, protein, fat, sodium, Vitamin C, Vitamin E, pantothenic acid, Zinc, iodine, Vitamin A, Magnesium, Folate, Vitamin D, Vitamin 12

Dietary Supplement: Multivitamin Gummies

Interventions

Curcumin GummiesDIETARY_SUPPLEMENT

Chew gummies thoroughly and completely before swallowing.

Also known as: curcumin
Curcumin Gummies
Vitamin C GummiesDIETARY_SUPPLEMENT

Chew gummies thoroughly and completely before swallowing.

Also known as: Vitamin C
Vitamin C Gummies
Multivitamin GummiesDIETARY_SUPPLEMENT

Chew gummies thoroughly and completely before swallowing.

Also known as: Multivitamin
Multivitamin Gummies

Eligibility Criteria

Age2 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age: 02 to 12 years old (both inclusive) at the time of parental consent.
  • Overall good health of the child subject is determined by medical examination and history evaluated by the Investigator.
  • Subject's mother/legal guardian, preferably willing to give a voluntary written informed consent i.e. parental informed consent form and agree to complete study activities and come for regular follow-up with a subject.
  • The subject's mother/legal guardian for their child is preferably willing to abide by and comply with the study protocol.
  • The subject should not participate in any other clinical study during participation in the current study
  • Subject are agreed to maintain current level of activity through the study.

You may not qualify if:

  • Subjects with known history of allergies or specific allergic reactions upon using curcumin, vitamins, zinc, pantothenic acid.
  • Subjects who are currently enrolled in an active investigational study or have participated in an investigational study within 30 days prior to enrolment.
  • Subjects, who in the opinion of the Investigator or the Expert physician are not eligible for enrolment in the study.
  • Subject who are unwilling to provide consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NovoBliss Research Pvt Ltd

Gandhinagar, Gujarat, 382421, India

Location

MeSH Terms

Interventions

CurcuminAscorbic AcidGeritol

Intervention Hierarchy (Ancestors)

DiarylheptanoidsHeptanesAlkanesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicSugar AcidsAcids, AcyclicCarboxylic AcidsHydroxy AcidsCarbohydrates

Study Officials

  • Dr. Chitra Prajapati, MBBS

    Principal Investigator

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This Study is Open-label
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: An Open-Label, Three-Arm, Parallel, Investigator-Initiated Trial of clinical study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 7, 2023

First Posted

March 20, 2023

Study Start

May 1, 2023

Primary Completion

June 1, 2023

Study Completion

July 6, 2023

Last Updated

November 9, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations